RU96124148A - COMPOSITION FOR CAPSULES - Google Patents
COMPOSITION FOR CAPSULESInfo
- Publication number
- RU96124148A RU96124148A RU96124148/14A RU96124148A RU96124148A RU 96124148 A RU96124148 A RU 96124148A RU 96124148/14 A RU96124148/14 A RU 96124148/14A RU 96124148 A RU96124148 A RU 96124148A RU 96124148 A RU96124148 A RU 96124148A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- capsules
- tetrahydropyrimidine
- dioxo
- sucrose
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title claims 2
- 239000000203 mixture Substances 0.000 title claims 2
- SHVCSCWHWMSGTE-UHFFFAOYSA-N 6-methyluracil Chemical compound CC1=CC(=O)NC(=O)N1 SHVCSCWHWMSGTE-UHFFFAOYSA-N 0.000 claims 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L Calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims 2
- 239000008116 calcium stearate Substances 0.000 claims 2
- 235000013539 calcium stearate Nutrition 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 239000000454 talc Substances 0.000 claims 2
- 229910052623 talc Inorganic materials 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 1
Claims (1)
2,4-диоксо-6-метил-1,2,3,4-тетрагидропиримидин β-форма - 9,30-19,95
Тальк - 3,00
Стеарат кальция - 1,00
Сахароза - 82,05-86,70Composition for capsules containing talc, calcium stearate, sucrose, characterized in that as the active substance it includes 2,4-dioxo-6-methyl-1,2,3,4-tetrahydropyrimidine β-form in the following ratio of components, wt .%:
2,4-dioxo-6-methyl-1,2,3,4-tetrahydropyrimidine β-form - 9.30-19.95
Talc - 3.00
Calcium Stearate - 1.00
Sucrose - 82.05-86.70
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU96124148/15A RU2363469C2 (en) | 1996-12-24 | 1996-12-24 | Compound for capsules |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU96124148/15A RU2363469C2 (en) | 1996-12-24 | 1996-12-24 | Compound for capsules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU96124148A true RU96124148A (en) | 1999-02-27 |
| RU2145846C1 RU2145846C1 (en) | 2000-02-27 |
| RU2363469C2 RU2363469C2 (en) | 2009-08-10 |
Family
ID=20188430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU96124148/15A RU2363469C2 (en) | 1996-12-24 | 1996-12-24 | Compound for capsules |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2363469C2 (en) |
-
1996
- 1996-12-24 RU RU96124148/15A patent/RU2363469C2/en active IP Right Maintenance
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103567A3 (en) | 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same | |
| ITRM920361A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ALLYLAMINE COMPOUND AS THE ACTIVE INGREDIENT. | |
| DK0747050T3 (en) | Pharmaceutical compositions containing irbesartan | |
| HUP9901199A3 (en) | Tropane-derivatives, inhibiting neurotransmitter re-uptake, their preparation, pharmaceutical compositions containing them and use of the compounds | |
| ZA981627B (en) | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds. | |
| HUP0102453A3 (en) | Adenosine derivatives, their use and pharmaceutical compositions containing the compounds | |
| IS2340B (en) | Solid pharmaceutical composition containing benzofuran derivatives | |
| HUP9903336A3 (en) | Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds and pharmaceutical compositions containing the same | |
| IL140897A0 (en) | Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL139529A0 (en) | Platinum complexes, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| CA2378428A1 (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
| HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
| IS5958A (en) | 3, 4, 5 triple-accessible arylonitrone compounds and pharmaceutical compositions containing such compounds | |
| ZA9710272B (en) | Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds. | |
| IL139318A (en) | Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same | |
| SE9802937D0 (en) | Novel compounds | |
| ITRM920734A1 (en) | COMPOSITIONS FOR THE STABILIZATION OF POLYMERS. (CASE 153-5550) | |
| CA2322027A1 (en) | Use of macrolide compounds for the treatment of ards | |
| RU96124148A (en) | COMPOSITION FOR CAPSULES | |
| RU96124149A (en) | COMPOSITION FOR CAPSULES | |
| WO1998034949A3 (en) | Monocyclic compounds with four bifunctional residues having nk-2 antagonist action | |
| EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
| CA2299503A1 (en) | Anti-first-pass effect compounds | |
| RU95121870A (en) | COMPOSITION HAS ANTI-TUMOR ACTION | |
| NZ505085A (en) | Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi |